TNFRSF9 and neoplasm: Further studies in this area will be important to assess whether other signaling pathway (e.g., HIF-1α, is also known to induce CD7338,40) does lead to any functional response involving interaction with 4-1BB ligation to boost anti-tumor T cell activity.